Publication Details

Pubmed25517749
Title: ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.
Year: 2014
DOI: https://doi.org/10.1016/j.ccell.2014.09.019
First Author: Bresler
Experimental setup: protein kinase assay (IntAct)

Interactions

1 interaction
InteractorPartnerSourcesLink
ALK_HUMANALK_HUMANIntActdetails